GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sarana Meditama Metropolitan Tbk PT SAME.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

228

+0.88%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 1.86trn

FY2016FY2025

Net income

IDR 30.08bn

FY2016FY2025

Free cash flow

IDR 14.87bn

FY2016FY2025

Shareholders' equity

IDR 3.80trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueIDR 1.86trnIDR 1.71trnIDR 1.53trnIDR 1.39trnIDR 1.27trnIDR 507.62bnIDR 529.32bnIDR 952.08bnIDR 775.57bnIDR 635.02bn
Gross profitIDR 476.55bnIDR 514.20bnIDR 434.04bnIDR 476.93bnIDR 542.57bnIDR 232.04bnIDR 212.48bnIDR 425.05bnIDR 356.64bnIDR 295.76bn
Operating incomeIDR 111.45bnIDR 119.92bnIDR 47.33bnIDR 62.23bnIDR 176.58bnIDR 8.64bnIDR 5.41bnIDR 160.69bnIDR 210.29bnIDR 70.45bn
Net incomeIDR 30.08bnIDR 11.85bnIDR 12.25bnIDR 9.58bnIDR 144.17bn−IDR 449.47bn−IDR 114.39bnIDR 58.88bnIDR 72.01bnIDR 14.80bn
Diluted earnings per share1.750.690.710.5610.64-33.35-12.626.507.941.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsIDR 5.80trnIDR 5.56trnIDR 5.36trnIDR 5.14trnIDR 4.95trnIDR 1.89trnIDR 2.23trnIDR 2.53trnIDR 1.71trnIDR 1.45trn
Cash and short-term investmentsIDR 152.45bnIDR 151.26bnIDR 149.78bnIDR 314.14bnIDR 625.07bnIDR 26.17bnIDR 22.70bnIDR 102.86bnIDR 64.34bnIDR 46.12bn
Total liabilitiesIDR 1.64trnIDR 1.42trnIDR 1.38trnIDR 1.16trnIDR 517.06bnIDR 1.34trnIDR 1.26trnIDR 1.20trnIDR 672.45bnIDR 600.93bn
DebtIDR 1.08trnIDR 969.69bnIDR 963.22bnIDR 742.58bnIDR 44.19bnIDR 1.08trnIDR 1.09trnIDR 1.03trnIDR 513.03bnIDR 459.29bn
Shareholders' equityIDR 3.80trnIDR 3.78trnIDR 3.64trnIDR 3.62trnIDR 3.84trnIDR 545.82bnIDR 977.49bnIDR 1.33trnIDR 1.04trnIDR 850.96bn
Shares outstanding17,156m17,147m17,138m17,130m13,544m13,477m9,066m9,066m9,066m9,066m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsIDR 357.02bnIDR 263.42bnIDR 151.55bnIDR 9.58bnIDR 253.74bn−IDR 21.67bnIDR 188.40bnIDR 31.31bnIDR 66.26bnIDR 123.85bn
Capital spending−IDR 342.15bn−IDR 287.41bn−IDR 515.52bn−IDR 240.72bn−IDR 139.04bn−IDR 6.73bn−IDR 369.36bn−IDR 489.66bn−IDR 78.41bn−IDR 296.62bn
Free cash flowIDR 14.87bn−IDR 23.99bn−IDR 363.97bn−IDR 231.13bnIDR 114.70bn−IDR 28.40bn−IDR 180.96bn−IDR 458.35bn−IDR 12.16bn−IDR 172.77bn
Dividends paid———−IDR 16.12bn———−IDR 10.03bn−IDR 3.54bn−IDR 8.26bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin25.6%30.1%28.3%34.2%42.7%45.7%
Operating margin6.0%7.0%3.1%4.5%13.9%1.7%
Net margin1.6%0.7%0.8%0.7%11.3%-88.5%
Return on equity0.8%0.3%0.3%0.3%3.8%-82.3%
Return on assets0.5%0.2%0.2%0.2%2.9%-23.8%
Free cash flow yield13.7%10.8%13.1%4.9%9.7%-0.4%
Revenue growth9.1%11.4%9.9%9.6%150.5%-4.1%
Earnings growth153.8%-3.3%27.9%-93.4%-132.1%292.9%
Current ratio0.53x0.74x0.87x1.54x2.59x0.45x
Debt to equity0.28x0.26x0.26x0.20x0.01x1.90x
Equity ratio65.5%68.0%67.8%70.5%77.5%28.9%
Interest coverage1.41x1.40x0.62x1.35x4.30x0.08x
Buybacks as a share of market value-0.1%-0.1%-0.1%-26.5%-0.5%-48.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.1%29.7%13.7%
Operating income21.4%66.8%-0.6%
Net income46.4%—-6.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.8%29.3%32.4%36.1%
Operating margin6.5%5.3%6.4%9.3%
Net margin1.2%1.0%-2.9%-1.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings206.5382.1439.2—34.8-3.6-8.135.429.5140.9
Price to sales3.32.63.53.73.93.21.82.22.73.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 18 May 2018.

FY2018FY2017FY2016FY2015
Paid in the year1.1060.601.401.40
  • 5-for-1 split · 2 Jun 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.